Effect on the incidence of exacerbations of a programme of physical activity encouragement using pedometers in patients with chronic obstructive pulmonary disease

Effect on the incidence of exacerbations of a programme of physical activity encouragement using pedometers in patients with Chronic Obstructive Pulmonary Disease: A randomized multicenter clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN58113014

Enrollment

Registered

2024-07-02

Start date

2022-08-29

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exacerbations in patients with Chronic Obstructive Pulmonary Disease Respiratory

Interventions

Experimental Group (EG): Patients assigned to the EG will receive the physical activity incentive program supported by step counters, where the kinesiology professional will teach them how to use the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. COPD patients 2. 40 years old and older 3. Ex smokers

Exclusion criteria

Exclusion criteria: 1. Exacerbations until 2 months before recruitment 2. Not able to walk

Design outcomes

Primary

Measure	Time frame
Baseline, 6-month, and 12-month (final) assessments include the following measurements: 1. Anthropometric measurements: Weight, height, determination of body mass index (BMI). 2. Pre- and post-bronchodilator spirometry 3. Quality of life assessment using the Saint George Quality of Life Questionnaire (SGRQ) and the abbreviated questionnaire: COPD Assessment Test (CAT) 4. Dyspnea assessment using the modified Medical Research Council (mMRC) scale	—

Measure

Time frame

Baseline, 6-month, and 12-month (final) assessments include the following measurements: 1. Anthropometric measurements: Weight, height, determination of body mass index (BMI). 2. Pre- and post-bronchodilator spirometry 3. Quality of life assessment using the Saint George Quality of Life Questionnaire (SGRQ) and the abbreviated questionnaire: COPD Assessment Test (CAT) 4. Dyspnea assessment using the modified Medical Research Council (mMRC) scale

—

Secondary

Measure	Time frame
Measured at baseline, 6-month, and 12-month (final) assessments: 1. Determination of physical activity level by: 1.1. Delivery of an accelerometer that will be indicated to be used during the day for a full week, which determines average hours per day with light, moderate, and vigorous physical activity levels. 1.2. Determination of the number of steps walked per day obtained by averaging the results in 1 week using the step counter with a screen sealed with masking tape. The step counter that will be used in the study has a memory of 7 previous days. 1.3. Proactive Questionnaire 2. Determination of exercise capacity by determining the distance traveled in 6 minutes (DR6) in the six-minute walk (C6M) and the 1-minute "sit to stand" test.	—

Measure

Time frame

Measured at baseline, 6-month, and 12-month (final) assessments: 1. Determination of physical activity level by: 1.1. Delivery of an accelerometer that will be indicated to be used during the day for a full week, which determines average hours per day with light, moderate, and vigorous physical activity levels. 1.2. Determination of the number of steps walked per day obtained by averaging the results in 1 week using the step counter with a screen sealed with masking tape. The step counter that will be used in the study has a memory of 7 previous days. 1.3. Proactive Questionnaire 2. Determination of exercise capacity by determining the distance traveled in 6 minutes (DR6) in the six-minute walk (C6M) and the 1-minute "sit to stand" test.

—

Countries

Chile

Contacts

Public ContactLaura Mendoza

lmendoza@hcuch.cl+56 229788409

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026